Demethoxycurcumin Inhibits In Vivo Growth of Xenograft Tumors of Human Cervical Cancer Cells

Conclusion: These effects and findings might provide evidence for investigating the potential use of DMC as an anti-cervical cancer drug in the future.

Source: In Vivo - August 30, 2020 Category: Research Authors: CHUEH, F.-S., LIEN, J.-C., CHOU, Y.-C., HUANG, W.-W., HUANG, Y.-P., HUANG, J.-Y., KUO, J.-Y., HUANG, W.-N., SHENG, S.-Y., TUNG, H.-Y., CHEN, H.-Y., PENG, S.-F. Tags: Experimental Studies Source Type: research